HIV Diagnosis Market - How the market developments of key players impact the overall industry?

By -

The HIV diagnosis market is projected to reach USD 3.88 Billion by 2021 from USD 2.35 Billion in 2016, at a CAGR of 10.5%

(EMAILWIRE.COM, January 26, 2019 ) The HIV diagnosis market is projected to reach USD 3.88 Billion by 2021 from USD 2.35 Billion in 2016, at a CAGR of 10.5% from 2016 to 2021.
The major players in the HIV diagnosis market are Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Thermo-Fisher Scientific Inc. (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Hologic, Inc. (US), Alere Inc. (US), and Bio-Rad Laboratories (US).
Target Audience for this Report:
• Manufacturers of HIV Diagnosis Products
• Vendors and Distributors of Powered Surgical Instruments
• Hospitals
• Research Institutes Related to HIV/AIDS Studies
• Venture Capitalists and Investors
Value Addition for the Buyer:
This report provides insights into the global HIV diagnosis market. It provides valuable information on the products, test type, and regions in the HIV diagnosis market. The geographic analysis for these segments is also presented in this report. Leading players in the market are profiled to study their device offerings and understand strategies undertaken by them to be competitive in this market.
The above-mentioned information would help the buyer understand market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize on the growth opportunities.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=66008285
Major Market Developments
• In March 2014, Siemens released a software upgrade for the RAPIDComm Data Management System, a solution to centrally manage Siemens’ in vitro diagnostics analyzers and operators at the point-of-care.
• In December 2016, Siemens Healthineers invested USD 300 million in its Walpole, Massachusetts facility to manufacture ADVIA Centaur family of immunoassay instruments.
• In June 2016, Roche launched Cobas e 801 module which offers more than 100 immunoassays and a wide range of disease diagnostics.
• In May 2015, Thermo Fisher launched iBind Flex Western device, working on the western blot technique for detection of infection.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com

Media Contact

Related Tags

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more